These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16968916)

  • 41. Causal prophylactic efficacy of atovaquone-proguanil (Malarone) in a human challenge model.
    Berman JD; Nielsen R; Chulay JD; Dowler M; Kain KC; Kester KE; Williams J; Whelen AC; Shmuklarsky MJ
    Trans R Soc Trop Med Hyg; 2001; 95(4):429-32. PubMed ID: 11579890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria.
    Shanks GD; Gordon DM; Klotz FW; Aleman GM; Oloo AJ; Sadie D; Scott TR
    Clin Infect Dis; 1998 Sep; 27(3):494-9. PubMed ID: 9770146
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Malaria prophylaxis with proguanil and sulfisoxazole in children living in a malaria endemic area.
    Pang LW; Limsomwong N; Singharaj P; Canfield CJ
    Bull World Health Organ; 1989; 67(1):51-8. PubMed ID: 2706727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force.
    Edstein MD; Walsh DS; Eamsila C; Sasiprapha T; Nasveld PE; Kitchener S; Rieckmann KH
    Med Trop (Mars); 2001; 61(1):56-8. PubMed ID: 11584657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relapsing vivax malaria after 6 months of daily atovaquone/proguanil in Afghanistan: the case for expanded use of primaquine as a causal prophylactic.
    Maguire JD; Llewellyn DM
    J Travel Med; 2007; 14(6):411-4. PubMed ID: 17995538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax.
    Mavrogordato A; Lever AM
    J Infect; 2012 Sep; 65(3):269-74. PubMed ID: 22609735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stevens-Johnson syndrome associated with Malarone antimalarial prophylaxis.
    Emberger M; Lechner AM; Zelger B
    Clin Infect Dis; 2003 Jul; 37(1):e5-7. PubMed ID: 12830430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atovaquone/Proguanil (Malarone) for malaria.
    Med Lett Drugs Ther; 2000 Nov; 42(1093):109-11. PubMed ID: 11093830
    [No Abstract]   [Full Text] [Related]  

  • 49. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
    Schwartz E; Bujanover S; Kain KC
    Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A public-private partnership for malaria control: lessons from the Malarone Donation Programme.
    Oyediran AB; Ddumba EM; Ochola SA; Lucas AO; Koporc K; Dowdle WR
    Bull World Health Organ; 2002; 80(10):817-21. PubMed ID: 12471403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity. A randomized, double-blind, placebo-controlled trial.
    Soto J; Toledo J; Rodriquez M; Sanchez J; Herrera R; Padilla J; Berman J
    Ann Intern Med; 1998 Aug; 129(3):241-4. PubMed ID: 9696733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primaquine for prevention of malaria in travelers.
    Baird JK; Fryauff DJ; Hoffman SL
    Clin Infect Dis; 2003 Dec; 37(12):1659-67. PubMed ID: 14689349
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.
    Shanks GD; Oloo AJ; Aleman GM; Ohrt C; Klotz FW; Braitman D; Horton J; Brueckner R
    Clin Infect Dis; 2001 Dec; 33(12):1968-74. PubMed ID: 11700577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malaria prophylaxis for the 1990s and beyond.
    Whitty CJ
    Br J Hosp Med; 1997 Dec; 58(11):545-6. PubMed ID: 10193466
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasmodium relictum (lineage P-SGS1): Further observation of effects on experimentally infected passeriform birds, with remarks on treatment with Malarone.
    Palinauskas V; Valkiūnas G; Krizanauskiene A; Bensch S; Bolshakov CV
    Exp Parasitol; 2009 Oct; 123(2):134-9. PubMed ID: 19545566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of chloroquine-proguanil malaria prophylaxis in a non-immune population in Bangui, Central African Republic: a case-control study.
    Matsika-Claquin MD; Ménard D; Fontanet AL; Ngwhotue A; Sarda J; Talarmin A
    Trans R Soc Trop Med Hyg; 2006 Apr; 100(4):381-6. PubMed ID: 16313935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Malaria chemoprophylaxis in traveling children].
    Minodier P; Noël G; Blanc P; Tsaregorodtseva N; Retornaz K; Garnier JM
    Arch Pediatr; 2005 Jan; 12(1):53-8. PubMed ID: 15653056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Malaria chemoprophylaxis: what do the travelers choose, and how does pretravel consultation influence their final decision.
    Senn N; D'Acremont V; Landry P; Genton B
    Am J Trop Med Hyg; 2007 Dec; 77(6):1010-4. PubMed ID: 18165513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Assessment of the efficacy of antimalarial drugs in Tarapacá, in the Colombian Amazon basin].
    Osorio L; Pérez Ldel P; González IJ
    Biomedica; 2007 Mar; 27(1):133-40. PubMed ID: 17546230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.